D-0790-2022 Class III Terminated
FDA drug recall D-0790-2022 was initiated by American Health Packaging on Apr 12, 2022 and is designated Class III. Reason for recall: Subpotent Drug: Out of specification for assay. The recall status is terminated (terminated Dec 28, 2022). Affected quantity: 97,975 vials.
Recall details
- Product Type
- Drugs
- Report Date
- May 4, 2022
- Initiation Date
- Apr 12, 2022
- Termination Date
- Dec 28, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 97,975 vials
Product description
Cyanocobalamin Injection, USP, 1000 mcg per mL, For Intramuscular or Subcutaneous Use Only, 25 x 1 mL Vials, Rx only, Manufactured by: Eugia Pharma Specialties Limited, Hyderabad India for BluePoint Laboratories. NDC for Carton: 68001-509-60; NDC for vial: 68001-509-59
Reason for recall
Subpotent Drug: Out of specification for assay.
Distribution pattern
Alabama
Code information
Lots: CCC210008, CCC210009, Exp. 01/23
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0790-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026